The Division of Translational Radiation Sciences (DTRS) works with partners from across the spectrum of academic, industry, and government research to advance understanding of radiation effects in normal tissue and to identify effective strategies to enhance the clinical benefits of radiation therapy and mitigate the health dangers associated with excessive radiation.
Our experienced team includes support staff in the lab and in administrative management who are skilled in assessing research partners’ needs and quickly transitioning projects from planning stages to implementation.
Among our current and recent research partners are:
Federal
- Biomedical Advanced Research and Development Authority
- Brookhaven National Laboratory
- National Aeronautics and Space Administration
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
Academic
- Duke University, Durham, NC
- Johns Hopkins University, Baltimore, MD
- Indiana University School of Medicine, Indianapolis, IN
- MD Anderson Cancer Center, Houston, TX
- University of Central Florida, Orlando, FL
- Wake Forest University, Winston Salem, NC
- Stony Brook University, Stony Brook, NY
Industry
- Aeolus Pharmaceuticals
- Chrysalis BioTherapeutics
- Humanetics Corporation
- Imagilin Technology LLC
- Prometic
- Epistem LLC
- SNBL USA
- Varian Medical Systems